Table 3.
Quantitative data of the articles
| Countries | Year | Isolates | Cla | Amo | Met | Tet | Lev | Rif | Fur | Method | Ref. |
| (N) | (%) | (%) | (%) | (%) | (%) | (%) | (%) | ||||
| 2014 | 95 | 33.7 | E-Test | [20] | |||||||
| 2013 | 82 | 17.1 | 9.8 | 64.4 | 0 | DDM | [21] | ||||
| 2013 | 78 | 15.3 | 6.4 | 55.1 | DDM | [22] | |||||
| Iran | 2012 | 150 | 34 | 10 | 78.6 | 9.3 | 5.3 | E-T,ADM | [23] | ||
| 2012 | 112 | 14.3 | 28.6 | 76.8 | 18.7 | 28.6 | DDM | [24] | |||
| 2011 | 197 | 45.2 | 23.9 | 65.5 | 37.1 | 61.4 | DDM | [25] | |||
| 2011 | 42 | 14.3 | 2.4 | 40.5 | 4.8 | ADM | [26] | ||||
| 2010 | 121 | 5 | 20 | 44 | 3 | E-Test | [27] | ||||
| 2010 | 132 | 30 | 6.8 | 73.4 | 9 | E-Test | [28] | ||||
| 2014 | 73 | 80.8 | 0 | 58.9 | 12.3 | E-Test | [29] | ||||
| 2013 | 17731 | 21.5 | 0.1 | 95.4 | 20.6 | 0.1 | ADM | [30] | |||
| China | 2011 | 73 | 84.9 | 0 | 61.6 | 0 | 13.7 | 6.8 | PCR | [31] | |
| 2010 | 374 | 37.2 | 0.3 | 63.9 | 1.2 | 50.3 | E-Test | [32] | |||
| 2009 | 36 | 8.3 | 33.3 | 94.4 | 0 | 16.7 | DDM | [33] | |||
| 2014 | 124 | 36.2 | 0 | 2.1 | E-Test | [34] | |||||
| Japan | 2014 | 135 | 25.9 | 20.7 | E-Test | [35] | |||||
| 2014 | 1073 | 31.1 | 40.2 | ADM | [36] | ||||||
| 2013 | 204 | 86.4 | 8.2 | 71.3 | 57 | ADM | [37] | ||||
| 2011 | 153 | 55.6 | PCR | [38] | |||||||
| 2010 | 61 | 36.1 | 0 | 14.8 | ADM | [39] | |||||
| 2014 | 212 | 8.5 | 9 | 36.3 | 0 | ADM | [40] | ||||
| South Korea | 2013 | 165 | 11.5 | 2.45 | 50.7 | 0 | 24.55 | ADM | [41] | ||
| 2013 | 150 | 6 | ADM | [42] | |||||||
| 2012 | 185 | 10.8 | 2.2 | 30.3 | 0.05 | ADM | [43] | ||||
| 2014 | 161 | 1.2 | 36.6 | E-Test | [44] | ||||||
| Malaysia | 2014 | 102 | 6.8 | 0 | 32.3 | 0 | 6.8 | 0 | E-Test | [45] | |
| 2011 | 90 | 0 | 0 | 75.5 | 0 | 14.4 | E-Test | [46] | |||
| 2011 | 187 | 2.1 | 0 | 37.4 | 0 | 1 | E-Test | [47] | |||
| 2009 | 187 | 2.1 | E-Test | [48] | |||||||
| 2014 | 46 | 47.8 | 54.3 | 73.9 | 4.3 | E-Test | [49] | ||||
| Pakistan | 2012 | 178 | 36 | 37 | 89 | 12 | ADM | [50] | |||
| 2010 | 92 | 33 | 2 | 48 | E-Test | [51] | |||||
| 2014 | 98 | 23.5 | 3.9 | 11.7 | DDM | [52] | |||||
| 2012 | 149 | 18.2 | 0 | 45.5 | 18.2 | E-Test | [53] | ||||
| Turkey | 2012 | 61 | 21.3 | 0 | 42.6 | 9.1 | 3.3 | DDM | [54] | ||
| 2009 | 31 | 41.9 | 3.2 | 41.9 | 3.2 | E-Test | [55] | ||||
| 2009 | 38 | 13.5 | ADM | [56] | |||||||
| Taiwan | 2014 | 61 | 35.3 | 0 | 17.6 | 0 | 23.5 | E-Test | [57] | ||
| 2009 | 180 | 10.6 | 0 | 26.7 | 9.4 | E-Test | [58] | ||||
| Thailand | 2009 | 120 | 29.2 | PCR | [59] | ||||||
| UAE | 2010 | 26 | 19.2 | E-Test | [60] | ||||||
| India | 2014 | 80 | 58.8 | 72.5 | 83.8 | 53.8 | 13.8 | 13.8 | DDM | [61] | |
| Vietnam | 2013 | 103 | 33 | 0 | 69.9 | 5.8 | 18.4 | E-Test | [62] | ||
| South American | |||||||||||
| 2014 | 54 | 11.1 | 1.9 | E-Test | [63] | ||||||
| Brazil | 2013 | 77 | 19.5 | 10.4 | 40 | 0 | 0 | ADM | [64] | ||
| 2011 | 39 | 8 | 0 | 51 | 0 | 23 | 0 | ADM | [65] | ||
| Colombia | 2012 | 203 | 19.8 | 20.5 | ADM | [66] | |||||
| Cuba | 2010 | 40 | 10 | 85 | E-Test | [67] | |||||
| PCR | |||||||||||
| Peru | 2011 | 95 | 36.9 | ADM | [68] | ||||||
| DDM | |||||||||||
| Uruguay | 2009 | 79 | 8.9 | 0 | 35.4 | 0 | 3.8 | E-Test | [69] | ||
| North America | |||||||||||
| Mexico | 2011 | 90 | 5.5 | 19 | E-Test | [70] | |||||
| Canada | 2009 | 42 | 57 | E-Test | [71] | ||||||
| United States | 2011 | 686 | 30 | 2 | 42 | 0 | 19 | E-Test | [72] | ||
| ADM | |||||||||||
| Senegal | 2013 | 108 | 1 | 0 | 85 | 0 | 15 | E-test | [73] | ||
| DDM | |||||||||||
| Nigeria | 2009 | 186 | 66 | 95 | 100 | E-test | [74] | ||||
| Gambia | 2012 | 64 | 0 | 68.8 | ADM | [75] | |||||
| Tunisia | 2010 | 273 | 15.4 | 0 | 51.3 | E-test | [76] | ||||
| South Africa | 2010 | 200 | 97.5 | ADM | [77] | ||||||
| DDM | |||||||||||
| 2014 | 1651 | 6.7 | 29.4 | E-test | [78] | ||||||
| Germany | 2013 | 5296 | 67.1 | 0 | 67.1 | 24.9 | E-test | [79] | |||
| 2013 | 436 | 7.5 | 0 | 32.7 | 11.7 | E-test | [80] | ||||
| Italy | 2012 | 111 | 35.2 | 59.3 | 22.1 | E-test | [81] | ||||
| 2011 | 253 | 9.9 | PCR | [82] | |||||||
| England | 2009 | 255 | 1 | E-test DDM | [83] | ||||||
| 2013 | 343 | 23.5 | 33 | E-test | [84] | ||||||
| Spain | 2011 | 71 | 14.7 | 1.4 | 45.1 | 0 | 14.5 | E-test | [85] | ||
| 2010 | 118 | 35.6 | E-test | [86] | |||||||
| 2009 | 101 | 54.6 | 35.7 | E-test | [87] | ||||||
| Norway | 2012 | 102 | 5.9 | 0 | 22.5 | 0 | E-test | [88] | |||
| Finland | 2010 | 505 | 8 | 0 | 41 | 7 | E-test | [89] | |||
| 2013 | 588 | 20.1 | 34.5 | 2.6 | ADM | [90] | |||||
| Bulgaria | 2011 | 519 | 17.9 | 29.5 | 4 | ADM | [91] | ||||
| 2009 | 1057 | 18.7 | 0.5 | 21.35 | 3.15 | ADM | [92] | ||||
| Croatia | 2012 | 382 | 11.9 | 0.6 | 10.1 | E-test | [93] | ||||
| 2014 | 210 | 8.1 | E-test | [94] | |||||||
| Poland | 2013 | 165 | 10.9 | 32.7 | 1.2 | E-test | [95] | ||||
| 2012 | 51 | 22 | 16 | E-test | [96] | ||||||
| 2011 | 115 | 34 | 0 | 44 | 5 | E-test | [97] | ||||
| Portugal | 2014 | 180 | 50 | 0.6 | 34.4 | 0.6 | 33.9 | E-test | [98] | ||
| 2011 | 1115 | 34.7 | 0 | 13.9 | 0 | E-test | [99] | ||||
| Belgium | 2013 | 189 | 13.3 | 0.8 | 26.1 | [100] | |||||
| 2011 | 10670 | 20.3 | 0 | 27 | ADM | [101] | |||||
| Netherlands | 2014 | 417 | 6.14 | 10.1 | E-test | [102] | |||||
| 2013 | 746 | 20.5 | 0.68 | 19.9 | E-test | [103] | |||||
| Ireland | 2013 | 85 | 0 | 11.7 | 0 | E-test | [104] | ||||
| 2010 | 219 | 13.2 | 31.5 | E-test | [105] | ||||||
| Southern Europe | 2014 | 74 | 34.7 | 16.7 | E-test | [106] |
Amo: Amoxicillin; Cla: Clarithromycin; Met: Metronidazole; Tet: Tetracycline; Lev: Levofloxacin; Rif: Rifabutin; Fur: Furazolidon; DDM: Disk Diffusion Agar; ADM: Agar Dilution Agar.